Header cover image

Hong Kong (HSI) Life Sciences Industry Analysis

UpdatedMay 28, 2025
DataAggregated Company Financials
Companies9
  • 7D1.5%
  • 3M-4.4%
  • 1Y91.2%
  • YTD25.6%

In the last week, the Life Sciences industry is up 1.5%, with Genscript Biotech up 22%. This means that the industry has gained 91% over the past year. Looking forward, earnings are forecast to grow by 32% annually.

Industry Valuation and Performance

Has the Hong Kong Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 May 2025HK$197.7bHK$36.1bHK$2.6b26.4x76.1x5.5x
Fri, 25 Apr 2025HK$188.8bHK$35.4bHK$2.5b25.9x74.5x5.3x
Sun, 23 Mar 2025HK$217.0bHK$32.6b-HK$203,413,550.8947.8x-1066.9x6.6x
Tue, 18 Feb 2025HK$192.5bHK$35.9b-HK$1,058,465,890.8560x-181.9x5.4x
Thu, 16 Jan 2025HK$149.2bHK$35.6b-HK$1,062,134,282.1557x-140.4x4.2x
Sat, 14 Dec 2024HK$154.0bHK$35.8b-HK$1,058,308,029.1758.8x-145.5x4.3x
Mon, 11 Nov 2024HK$154.2bHK$36.1b-HK$1,054,663,570.8441.4x-146.3x4.3x
Wed, 09 Oct 2024HK$174.7bHK$36.0b-HK$653,938,960.9034.1x-267.1x4.9x
Fri, 06 Sep 2024HK$149.5bHK$35.9b-HK$659,801,485.4923.4x-226.7x4.2x
Sun, 04 Aug 2024HK$97.0bHK$33.8bHK$3.1b19.4x31x2.9x
Tue, 02 Jul 2024HK$89.5bHK$33.4bHK$3.1b19.2x29.1x2.7x
Thu, 30 May 2024HK$91.4bHK$33.5bHK$3.1b28.5x29.6x2.7x
Sat, 27 Apr 2024HK$108.0bHK$33.6bHK$3.1b30.6x34.9x3.2x
Mon, 25 Mar 2024HK$111.8bHK$33.2bHK$3.7b52.8x30.6x3.4x
Wed, 21 Feb 2024HK$126.9bHK$32.3bHK$3.0b51.9x42.7x3.9x
Fri, 19 Jan 2024HK$204.3bHK$32.3bHK$3.0b89.1x68.6x6.3x
Sun, 17 Dec 2023HK$212.6bHK$32.5bHK$3.0b85.2x70.5x6.5x
Tue, 14 Nov 2023HK$263.8bHK$30.1bHK$2.7b46.7x98.7x8.8x
Thu, 12 Oct 2023HK$252.8bHK$30.1bHK$2.7b44.9x94.7x8.4x
Sat, 09 Sep 2023HK$223.8bHK$30.1bHK$2.7b40.1x84.3x7.4x
Mon, 07 Aug 2023HK$243.1bHK$28.5bHK$2.7b23.2x88.7x8.5x
Wed, 05 Jul 2023HK$214.0bHK$28.4bHK$2.7b21.1x78.7x7.5x
Fri, 02 Jun 2023HK$222.1bHK$28.8bHK$2.8b21.5x79.7x7.7x
Sun, 30 Apr 2023HK$249.3bHK$29.5bHK$2.9b24.5x85.3x8.5x
Tue, 28 Mar 2023HK$256.4bHK$28.9bHK$2.5b23.3x104.6x8.9x
Thu, 23 Feb 2023HK$288.3bHK$26.3bHK$2.1b25.3x140.3x10.9x
Sat, 21 Jan 2023HK$371.2bHK$26.6bHK$2.1b27.8x174.1x13.9x
Mon, 19 Dec 2022HK$275.0bHK$25.9bHK$2.0b26.9x138.6x10.6x
Wed, 16 Nov 2022HK$286.5bHK$25.8bHK$1.9b27.8x148.3x11.1x
Fri, 14 Oct 2022HK$237.6bHK$25.6bHK$1.9b19.4x127.3x9.3x
Sun, 11 Sep 2022HK$343.4bHK$26.3bHK$2.0b25.7x168.7x13.1x
Tue, 09 Aug 2022HK$386.6bHK$22.3bHK$2.0b12.1x189.7x17.4x
Thu, 07 Jul 2022HK$433.0bHK$22.4bHK$2.1b15.1x209.4x19.4x
Sat, 04 Jun 2022HK$299.3bHK$22.5bHK$2.1b13.1x142x13.3x
Price to Earnings Ratio

142x


Total Market Cap: HK$299.3bTotal Earnings: HK$2.1bTotal Revenue: HK$22.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Life Sciences Industry Price to Earnings3Y Average 33.2x202320242025
Current Industry PE
  • Investors are optimistic on the Hong Kong Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 76.1x which is higher than its 3-year average PE of 33.2x.
  • The 3-year average PS ratio of 7.5x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 7.2% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market0.04%
Healthcare3.13%
Life Sciences1.51%
Clinical Research and Equipment1.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1548 Genscript BiotechHK$12.6815.9%
+HK$3.8b
25.5%PS5.9x
1873 Viva Biotech HoldingsHK$1.804.0%
+HK$147.6m
185.7%PE20.8x
2576 Zhejiang Taimei Medical TechnologyHK$3.463.3%
+HK$62.0m
n/aPS3.2x
1521 Frontage HoldingsHK$1.140.9%
+HK$20.2m
-4.2%PE372.1x
8225 China Health GroupHK$0.173.1%
+HK$5.0m
47.3%PS5.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2269

HK$23.40

WuXi Biologics (Cayman)

7D

-5.3%

1Y

104.9%

1548

HK$12.68

Genscript Biotech

7D

15.9%

1Y

25.5%

8225

HK$0.17

China Health Group

7D

3.1%

1Y

47.3%

2228

HK$4.45

XtalPi Holdings

7D

-8.8%

1Y

n/a

2268

HK$36.80

WuXi XDC Cayman

7D

-4.0%

1Y

142.4%

2576

HK$3.46

Zhejiang Taimei Medical Technology

7D

3.3%

1Y

n/a

1521

HK$1.14

Frontage Holdings

7D

0.9%

1Y

-4.2%